Lots of interesting abstracts and cases were submitted for TCTAP & AP VALVES 2020 Virtual. Below are accepted ones after thoroughly reviewed by our official reviewers. Don¡¯t miss the opportunity to explore your knowledge and interact with authors as well as virtual participants by sharing your opinion!

* The E-Science Station is well-optimized for PC.
We highly recommend you use a desktop computer or laptop to browse E-posters.

ABS20191114_0007
Gender Difference in Long-term Clinical Outcomes After Percutaneous Coronary Intervention - A Propensity-matched Analysis of National Health Insurance Data in the Republic of Korea
Seunghwa Lee1, Eun-Seok Shin2, Jin Ho Choi3, Joo Myung Lee3, Taek Kyu Park3, Jeong Hoon Yang3, Young Bin Song3, Joo-Yong Hahn3, Seung Hyuk Choi3, Hyeon-Cheol Gwon3, Sang Hoon Lee3
Wiltse Memorial Hospital, Korea (Republic of)1, Ulsan University Hospital, Korea (Republic of)2, Samsung Medical Center, Korea (Republic of)3
Background:
Despite the advances in the interventional technology, devices, and pharmacotherapy which have translated into better clinical outcome of patients undergoing percutaneous coronary intervention (PCI), there is still a disparity in the clinical outcome between women and men undergoing PCI.
Methods:
We retrospectively enrolled a nationwide cohort of all Korean PCI performed in year 2011. Primary outcome was 5-year cumulative incidence of major adverse clinical event (MACE) consisting of all-cause death, revascularization, critically ill cardiovascular status, or stroke. Outcomes adjusted with age and propensity for clinical characteristics were additionally compared.
Results:
In unadjusted analysis, female (N=15710) were older (69.7¡¾9.7 versus 62.0¡¾11.1year, p<0.001) and had higher frequency of comorbidities including hypertension, hyperlipidemia, and diabetes compared to male (N=33073) (p<0.001, all). female had higher 5-yearcumulative incidence of MACE than men (21.8% versus 17.3%; hazard ratio [HR] 1.29, 95% confidential interval [CI] 1.23 ? 1.34; p<0.001). However, in the analysis of age and propensity score-matched 14461 pairs, women had lower 5-year mortality risk (20.3% versus 26.1%, HR 0.85, 95% CI 0.82-0.88, p<0.001). This finding was consistent in subgroup analyses of age, risk factors, and clinical presentation such as acute myocardial infarction or stable angina (p<0.05, all).

Conclusion:
The apparent worse outcome in women can be explained by older age and more common comorbidities in women. After adjusting these disadvantages, women had better outcome after PCI than men.
like off